ConductScience.org, home

Paper7429331

Treatment of bone disease after jejunoileal bypass for obesity with oral 1 alpha-hydroxyvitamin D3.

Compston JE and 6 others. Gut, 1980. Cited by 16 papers, by iCite.

Cite this record

ConductScience Library. Treatment of bone disease after jejunoileal bypass for obesity with oral 1 alpha-hydroxyvitamin D3. Papers, record 7429331. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7429331

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Treatment of bone disease after jejunoileal bypass for obesity with oral 1 alpha-hydroxyvitamin D3.
PubMed
Journal
Gut
PubMed
Year
1980
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
16
iCite
Relative citation ratio, by iCite
0.91
iCite
Revised in PubMed
2019-05-01
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Compston JEJ E
2Horton LWL W
3Laker MFM F
4Merrett ALA L
5Woodhead JSJ S
6Gazet JCJ C
7Pilkington TRT R

Source PubMed

Download CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
HydroxycholecalciferolsMajor topic
HyperparathyroidismMajor topic
ObesityMajor topic
OsteomalaciaMajor topic
Postoperative ComplicationsMajor topic
Adult
Anti-Bacterial Agents
Female
Humans
Ileum
Jejunum
Male
Middle Aged

Source PubMed

Download CSV of topics

References18

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
15640921Degradation of bile salts by human intestinal bacteria.Gut1968https://conductscience.org/library/papers/5640921PubMed
24894738Tetracycline-based histological analysis of bone remodeling.Calcif Tissue Res1969https://conductscience.org/library/papers/4894738PubMed
35806503Steroids in germfree and conventional rats. 21-dehydroxylation by intestinal microorganisms.Eur J Biochem1969https://conductscience.org/library/papers/5806503PubMed
45418545Effect on hepatic morphology of treatment of obesity by fasting, reducing diets and small-bowel bypass.N Engl J Med1970https://conductscience.org/library/papers/5418545PubMed
55104552Immunoradiometric assay of parathyroid hormone.J Endocrinol1971https://conductscience.org/library/papers/5104552PubMed
64758544Interpretation of serum calcium in patients with abnormal serum proteins.Br Med J1973https://conductscience.org/library/papers/4758544PubMed
74361486Competitive protein-binding assay for 25-hydroxycholecalciferol.Clin Sci Mol Med1974https://conductscience.org/library/papers/4361486PubMed
84432049Bile acid metabolism and intestinal bacterial flora after three types of intestinal shunt operation for obesity.Scand J Gastroenterol1974https://conductscience.org/library/papers/4432049PubMed
94432050Calcium absorption and bone mineral contents following intestinal shunt operation in obesity.Scand J Gastroenterol1974https://conductscience.org/library/papers/4432050PubMed
1050513Nomogram for derivation of renal threshold phosphate concentration.Lancet1975https://conductscience.org/library/papers/50513PubMed
11115343625-Hydroxyvitamin D3: evidence of an enterohepatic circulation in man.Proc Soc Exp Biol Med1975https://conductscience.org/library/papers/1153436PubMed
12832019Rate of reversal of hypercalcaemia and hypercalciuria induced by vitamin D and its 1alpha-hydroxylated derivatives.Br Med J1977https://conductscience.org/library/papers/832019PubMed
13842987Abnormalities of circulating 25-OH vitamin D after jejunal-lleal bypass for obesity: evidence of an adaptive response.Ann Intern Med1977https://conductscience.org/library/papers/842987PubMed
149122691-alpha-hydroxycholecalciferol for renal osteodystrophy.Br Med J1977https://conductscience.org/library/papers/912269PubMed
15623077Significance of serum level of 25-hydroxycholecalciferol in gastrointestinal disease.Am J Dig Dis1978https://conductscience.org/library/papers/623077PubMed
16630809A radioimmunoassay for 1,25-dihydroxycholecalciferol.Clin Sci Mol Med1978https://conductscience.org/library/papers/630809PubMed
1778209Bone disease after jejuno-ileal bypass for obesity.Lancet1978https://conductscience.org/library/papers/78209PubMed
18677580Metabolic bone disease after intestinal bypass for treatment of obesity.Ann Intern Med1978https://conductscience.org/library/papers/677580PubMed

Download CSV of references

Cited by3

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 16 citations.

PMIDTitleJournalYearIn PapersSource
39351881Oral vitamin D supplementation for adults with obesity undergoing bariatric surgery.Cochrane Database Syst Rev2024https://conductscience.org/library/papers/39351881PubMed
3004848Severe osteomalacia associated with renal tubular acidosis in Crohn's disease.Dig Dis Sci1986https://conductscience.org/library/papers/3004848PubMed
1973395Effects of an enteric anaerobic bacterial culture supernatant and deoxycholate on intestinal calcium absorption and disaccharidase activity.Gut1990https://conductscience.org/library/papers/1973395PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/7429331

GET https://conductscience.org/api/papers/v1/7429331/authors